新型含哌嗪-磺酰胺的2(5H)-呋喃酮类化合物的合成及其抗癌活性

以糠醛为原料,经氧化、醚化和重结晶制得5-甲氧基-3,4-二溴-2(5H)-呋喃酮（4）; 4与哌嗪经Michael加成消除反应制得5-甲氧基-4-哌嗪基-3-溴-2(5H)-呋喃酮（5）; 5与取代磺酰氯经磺酰化反应合成了7 个新型的含哌嗪-磺酰胺的2(5H)-呋喃酮类化合物(7a~7g),其结构经¹H NMR, ¹³C NMR, IR和HR-MS表征。初步的生物活性研究(MTT法)表明,7a~7g均能显著抑制人宫颈癌Hela细胞的增殖,其中5-甲氧基-4-(对乙酰氨基苯磺酰基-哌嗪基)-3-溴-2(5H)-呋喃酮（7f）的抑制活性最佳,其IC₅₀为0.03 μM(24 h)。     

N-(4-哌啶基)苯甲酰胺衍生物的设计、合成及其抗肝癌活性

以4-羟基苯甲酸乙酯为原料,经烃化、水解、缩合、脱保护、磺酰化反应,合成了6个含有磺酰基取代的4-苯氧基-N-(4-哌啶基)苯甲酰胺衍生物。 其结构经¹H NMR、¹³C NMR和MS谱等技术手段进行了表征,并以索拉非尼为阳性对照药对HepG2细胞株进行了初步体外抗肝癌细胞增殖活性的评价。 实验发现,4-苯氧基-N-(1-甲磺酰基哌啶-4-基)苯甲酰胺的体外抗肝癌生物活性优于索拉非尼,IC₅₀值为8.42 μmol/L。 研究结果表明,新结构4-苯氧基-N-(4-哌啶基)苯甲酰胺类化合物具有良好的抗肝癌活性。     

新型含哌嗪1,3,4-噻二唑酰胺衍生物的合成及其生物活性

以氨基硫脲和二硫化碳为起始原料,合成了15个新型的1,3,4-噻二唑衍生物(6a~6o),其结构经¹H NMR,¹³C NMR,IR,ESI-MS和元素分析表征。生物活性测试结果表明：大部分化合物对水稻白叶枯细菌有良好的抑制活性,其中,N-［5-(2,4-二氯苄基)硫醚］-1,3,4-噻二唑-2-(2-N-甲基哌嗪)-乙酰胺(6b)和N-［5-(4-三氟甲氧基苄基)硫醚］-1,3,4-噻二唑-2-(2-N-甲基哌嗪)-乙酰胺(6e)的EC₅₀分别为17.5 μg·mL^-1和19.8 μg·mL^-1; N-[5-(3-甲基苄基)硫醚)-1,3,4-噻二唑-2-(2-哌嗪)-乙酰胺(6k)在浓度为500 μg·mL^-1时,对烟草花叶病毒有一定的抑制活性。     

Synthesis and X-ray crystal structures of [Ph2PMe2][(η-C5H4Bu)2Li] and [(η-C5H4Bu)2Yb(Cl)CH2P(Me)Ph2]

The interaction of [(η⁵-C₅H₄Bu^t)₂YbCl · LiCl] with one equivalent of Li[(CH₂) (CH₂)PPh₂] in tetrahydrofuran gave [Ph₂PMe₂][(η⁵-C₅H₄Bu^t)₂Li] (1) and [(η⁵-C₅H₄Bu^t)₂Yb(Cl)CH₂P(Me)Ph₂] (2) in 10% and 30% yields, respectively. 1 could also be prepared in 70% yield from the reaction of [Ph₂PMe₂][CF₃SO₃] with two equivalents of (C₅H₄Bu^t)Li. Both compounds have been fully characterized by analytical, spectroscopic and X-ray diffraction methods. The solid state structure of 1 reveals a sandwich structure for the [(η⁵-C₅H₄Bu^t)₂Li]⁻ anion.     

5-氟尿嘧啶修饰卟啉的合成及抗肿瘤活性

合成了一种5-氟尿嘧啶修饰的自由卟啉(5-[2-(5-氟尿嘧啶-3-基)乙氧基苯基]-10,15,20-三(4-甲氧基苯基)卟啉)及其2种金属卟啉配合物:5-[2-(5-氟尿嘧啶-3-基)乙氧基苯基]-10,15,20-三(4-甲氧基苯基)锰卟啉和5-[2-(5-氟尿嘧啶-3-基)乙氧基苯基]-10,15,20-三(4-甲氧基苯基)锌卟啉。 通过紫外可见光谱(UV-Vis)、红外光谱(IR)和核磁共振谱氢谱(¹H NMR)对目标化合物进行了结构表征。 用噻唑蓝法(MTT法)测定了自由卟啉、锰卟啉及锌卟啉分别对肺腺癌细胞株A549、肝癌细胞株Bel7402和人结肠癌细胞株HCT-8的抑制活性。 其中,锰卟啉对人结肠癌细胞株HCT-8的半抑制浓度为IC₅₀为17.8 mg/L,具有一定的细胞毒作用。     

Structures of propionaldehyde, butyraldehyde, and pivalaldehyde complexes of the chiral rhenium fragment [(η-C5H5)Re(NO)(PPh3)]

The crystal structures of propionaldehyde complex (RS,SR)-(η⁵-C₅H₅)Re(NO)(PPh₃)(η²-O=CHCH₂CH₃)]⁺ PF₆⁻ (1b⁺ PF₆^s−; monoclinic, P2₁/c (No. 14), a = 10.166 (1) Å, b = 18.316(1) Å, c = 14.872(2) Å, β = 100.51(1)°, Z = 4) and butyraldehyde complex (RS,SR)-[(η⁵-C₅H₅)Re(NO)(PPh₃)(η²-O=CHCH₂CH₂CH₃)]⁺ PF₆⁻ (1c⁺PF₆⁻; monoclinic, P2₁/a (No. 14), a = 14.851(1) Å, b = 18.623(3) Å, c = 10.026(2) Å, β = 102.95(1)°, Z = 4) have been determined at 22°C and −125°C, respectively. These exhibit C O bond lengths (1.35(1), 1.338(5) Å) that are intermediate between those of propionaldehyde (1.209(4) Å) and 1-propanol (1.41 Å). Other geometric features are analyzed. Reaction of [(η⁵-C₅H₅)Re(NO)(PPh₃)(ClCH₂Cl)]⁺ BF₄⁻ and pivalaldehyde gives [(η⁵-C₅H₅)Re(NO)(PPh₃)(η²-O=CHC(CH₃)₃)]⁺BF₄⁻ (81%), the spectroscopic properties of which establish a π C O binding mode.     

Development of bis-thiobarbiturates as successful urease inhibitors and their molecular modeling studies

Bis-thiobarbiturate derivatives 1–15 have been synthesized, characterized by1 HNMR and EI-MS and screened for urease inhibition. All compounds showed various degree of urease inhibitory activity with IC_(50) values ranging 7.45 0.12 74.24 0.81 mmol/L while the standard thiourea behaved normally(IC_(50) = 21.10 0.12). Compounds 1(IC_(50) = 7.45 0.12 μmol/L), 9(IC_(50) = 18.17 1.03 μmol/L) and 13(IC_(50) = 8.61 0.45 μmol/L) showed excellent urease inhibitory activity in the series. Molecular modeling studies were performed to understand the binding site with the bimetallic nickel center of the enzyme.Structure-activity relationship has also been established for these compounds. This study identified bisthiobarbiturate as a novel class of urease inhibitors.     

Cobalt and nickel complexes bearing 2,6-bis (imino) phenoxy ligands: syntheses, structures and oligomerization studies

A series of new cobalt and nickel complexes LMX₂ (M=Co, X=Cl; M=Ni, X=Br) bearing 2, 6-bis(imino)phenoxy ligands were synthesized. The solid-state structures of 1 and 4 have been determined by single-crystal X-ray diffraction study. Treatment of the complexes LMX₂ with methylaluminoxane (MAO) leads to active catalysts for oligomerization of ethylene with catalytic activities in the range of 1.2×10⁵–2.1×10⁵ g mol⁻¹ h⁻¹ atm⁻¹ for Ni complexes, and 10³ g mol⁻¹ h⁻¹ atm⁻¹ for Co complexes. The oligomers were olefins from C₄ to C₁₆.     

Pulse radiolysis of epicatechin in aqueous solution

Pulse radiolysis of epicatechin in aqueous solution has been done to investigate the reactions of epicatechin derived phenoxy radical (EpO) at neutral pH. EpO was generated by N₃ reacting toward EpOH, the rate constant was measured to be 3 × 10⁸ dm³ mol⁻¹ s⁻¹. The biomolecular termination of EpO is rather slow ((2k < × 10⁶ dm³ mol⁻¹ s⁻¹) and results in products exhibiting strong visible absorption around 450 nm. No reactions have been observed for EpO with O₂ and O₂ in the time scale of pulse radiolysis (0.01 s), suggesting the bimolecular rate constant are less than 10⁴ and 5 × 10⁶ dm³ mol⁻¹ s⁻¹, respectively.     

Cytotoxicities,Telomerase and Topoisomerases I Inhibitory Activities and Interactions of Terpyridine Derivatives with DNAs

A novel compound 4-methyl-7-{[4-(2,2':6',2'-terpyridin-4'-yl)benzyl]amino}-2H-chromen-2-one(1) was synthesized, and its DNA-binding properties, cytotoxicity, and telomerase and Topo I inhibitory activities were evaluated. For comparison, the anti-proliferative and Topo I inhibitory activities of another two analogues 2 and 3 were also investigated. Compound 1 is able to stabilize the structures of human telomere(h-tert) and promoter(c-myc and c-kit2) G-quadruplexes and h-tert i-motif. The association constants(K_b) are about 10⁶ L/mol for h-tert G-quadruplex and i-motif, while the values are about 10⁵ L/mol for both promoter G-qaudruplexes and calf thymus DNA(ct-DNA). The binding of compound 1 induces the change of h-tert G-quadruplex from hybrid to antiparallel structure and exhibits 88.7% inhibition of telomerase activity at 8 mmol/L. Both compounds 1 and 3 inhibit significantly Topo I-mediated relaxation of pBR322 DNA. Compounds 1 and 2 show a high inhibitory efficacy on HepG2 and MCF-7 cancer cell lines with IC₅₀ values of about 10^-6 mol/L. The three compounds also induce a delay of cell cycle progression. The coumarin group is vital for improving the biological activity of terpyridine derivatives.     

Coordination-driven self-assembly of palladium(Ⅱ)-based metallacalixarenes as anion receptors using flexible pyridine-bridged diimidazole ligands

Two types of palladiu m(Ⅱ)-based metallacalixarenes[ML]²⁺and[ML₂]²⁺have been synthesized through coordination-driven self-assembly from a series of flexible pyridine-bridged diimidazole ligands[2,6-bis((1 H-imidazol-1-yl)methyl)pyridine(L¹),2,6-bis((1 H-benzo[d]imidazol-1-yl)methyl)pyridine(L²),2,6-bis((1 H-naphtho[2,3-d]imidazol-1-yl)methyl)pyridine(L³)],with palladium(II)-based building blocks[Pd(BF₄)₂(M¹-BF_4)and(tmeda)Pd(NO₃)₂(M²-NO₃)(tmeda=N,N,N',N'-tetramethyl-ethylenediamine)].All complexes were characterized by NMR spectroscopy(¹H NMR and¹³C NMR),mass spectrometry(CSIMS,ESI-HRMS)and elemental analysis.The single crystal X-ray diffraction analysis of[M¹L²_2](NO₃)₂,[M¹L³_2](NO₃)₂,[M¹L³_2](PF_6)_2 and[M~2 L³](NO₃)₂further confirmed the uniquely single bowl-shape and double bowl-shape structures.The anion binding properties within the metallacalixarenes as receptors were also investigated by NMR titration experiments in DMSO.     

1,3,2-Diazastanna-[3]ferrocenophanes bearing alkyn-1-yl groups at tin and their 1,1-organoboration with triethylborane—molecular structure of a novel spirotin compound

2,2-Dichloro-1,3-bis(trimethylsilyl)-1,3,2-diazastanna-[3]ferrocenophane (3) reacts with lithium alkynides LiCCR¹ to give the corresponding di(alkyn-1-yl)tin derivatives 4a (R¹=^tBu) and 4b (R¹=SiMe₃). 1,1-Organoboration of 4 with triethylborane affords the spirotin compounds 5 which contain both a ferrocenophane and a stannacyclopentadiene ring. The crystal structure of 5b was determined by X-ray analysis. The compounds 4 and 5 were characterised in solution by multinuclear magnetic resonance (¹H-, ¹¹B-, ¹³C-, ¹⁵N-, ²⁹Si-, ¹¹⁹Sn-NMR), using pulsed field gradients in HMBC experiments for the ¹H detected ¹⁵N- and ¹¹⁹Sn-NMR signals. The compound 5b was also studied by solid-state ¹³C, ²⁹Si and ¹¹⁹Sn MAS NMR in order to correlate liquid and solid-state NMR data with the structural evidence.     

BCL-2选择性抑制剂——ABT-199的合成工艺改进

以3,3-二甲基环己酮(2)为原料,经5步反应制得中间体1-氯-4-［2-(氯甲基)-5,5-二甲基环己基-1-烯］苯（5）;以5-溴-7-氮杂吲哚为原料,经3步反应制得制得5-羟基-1-三异丙基硅基-7-氮杂吲哚（8）; 8与4-［3-氟-4-(甲氧基羰基)苯基］哌嗪-1-甲酸叔丁酯（9）经取代反应制得4-｛3-［(7-氮杂吲哚)氧］-4-(甲氧基羰基)苯基｝哌嗪-1-甲酸叔丁酯（10）;10脱保护后与5进行S_N2取代反应,所得中间体与3-硝基-4-｛［（四氢-2H-吡喃-4-基)甲基］氨基｝苯磺酰胺经缩合反应合成了BCL-2选择性抑制剂ABT-199,总收率28.4%,其结构经¹H NMR和ESI-MS确证。     

芳香查尔酮衍生物的合成、理论计算及三阶非线性光学性质

合成了2种新的具有潜在应用价值的非线性光学(NLO)有机材料芳香查尔酮衍生物1-(呋喃-2-基)-3-(4-甲氧基苯基)丙烯酮(1)和1-(噻吩-2-基)-3-(4-甲氧基苯基)丙烯酮(2),并对其进行了NMR、IR和HR-MS结构表征。 采用4f相位相干成像技术测定了化合物1和2的三阶NLO性质并确定了相关参数:脉冲宽度4 nm,激光波长440 nm,化合物1:非线性吸收系数β=5.5×10^-10 m/W,非线性折射系数n₂=-2.1×10^-17 m²/W,三阶非线性极化率χ⁽³⁾=1.58×10^-11 esu;化合物2:β=-2.4×10^-10 m/W,n₂=0.3×10^-17 m²/W,χ⁽³⁾=0.50×10^-11 esu;并测定了紫外光谱和DSC曲线。 采用密度泛函方法计算了化合物1和2的轨道能量和极化率,结果表明电子转移能在分子内部进行,说明比较易于极化,展示了良好的非线性光学性质。     

Metallorganische lewissäuren : XX. Reaktionen von (π-C5H5)(CO)2LM-X (L = CO, PR3; M = Mo, W; X = BF4, PF6, AsF6, SbF6) mit Schwefel-haltigen liganden

The compounds (π-C₅H₅)(CO)₂LM-X (L = CO, PR₃; M = Mo, W; X = BF₄, PF₆, AsF₆, SbF₆) react with H₂S, p-MeC₆H₄SH, Ph₂S and Ph₂SO(L′) to give ionic complexes [(π-C₅H₅)(CO)₂LML′]⁺ X⁻. Also sulfur-bridged complexes, [(π-C₅H₅)(CO)₃W---SH---W(CO)₃(π-C₅H₅)]⁺ AsF₆⁻ and [(π-C₅H₅)(CO)₃M-μ-S₂C=NCH₂Ph-M(CO)₃(π-C₅H₅)], have been obtained. Reactions with SO₂ and CS₂ have been examined.     

Synthesis of bimetallic[Sn,A]-μ-oxoisopropoxyacetate and -μ-oxoisopropoxide and their acetylacetone and benzoylacetone derivatives

Bimetallic [Sn^IV,Al^III-μ-oxoisopropoxyacetate (Bu₂Sn(OAc)OAl(OⁱPr)₂] and bimetallic [Sn^IV,Al^III]-μ- oxoisopropoxide [Bu₂SnO₂Al₂(OⁱPr)₄] have been synthesized by thermal condensation of dibutyltin diacetate with aluminium isopropoxide in 1:1 and 1:2 molar ratio, respectively. Reactions of these compounds with acetylacetone and benzoylacetone in these molar ratios yielded compounds of the type [Bu₂Sn(OAc)OAl(OⁱPr)L], [Bu₂Sn(OAc)OAlL₂], [Bu₂SnO₂Al₂(OⁱPr)₃L] and [Bu₂SnO ₂Al₂(OⁱPr)₂L₂] (where L = acetylacetonate or benzoylacetonate anion). The μ-oxo compounds and their derivatives have been characterized by elemental analysis and spectroscopic techniques (IR, ¹H NMR, ¹³C NMR, ²⁷Al NMR and ¹¹⁹Sn NMR).     

2-(N-环己胺)-6-三氟甲氧基苯并噻唑的合成及其晶体结构

以利鲁唑为原料,与硫酸肼经回流反应制得2-肼基-6-三氟甲氧基苯并噻唑(2); 2经氯化亚砜氯代制得2-氯-6-三氟甲氧基苯并噻唑(3);3与环己胺经取代反应合成了新化合物2-(N-环己胺)-6-三氟甲氧基苯并噻唑(4),其结构经¹H NMR, IR,元素分析和X-射线单晶衍射表征。4 (CCDC：1 440 686)属三斜晶系,P-1空间群,晶胞参数a=10.617(3) , b=13.607(4) , c=16.619(5) , V=2 201.8 ³, Dc=1.422 g·cm^-3, Z=6, R₁=0.082 0, wR₂=0.235 1。     

Complexes of heteroscorpionate trispyrazolylborate ligands. Part XI. Weak CH/π interactions in crystals of hydrotris(3-phenylpyrazolyl)boratothallium(I) and hydrobis(5-methyl-3-phenylpyrazolyl)(3,5-dimethylpyrazol-yl)boratothallium(I) studied by X-ray crystallography

Thallium(I) complexes of heteroscorpionate hydrobis(3-phenyl-5-methylpyrazolyl)(3,5-dimethylpyrazol-yl)borate and hydrotris(3-phenylpyrazol-1-yl)borate were studied crystallographically. Both ligands were coordinated in κ³ fashion via N₂ atoms of pyrazol-1-yl moieties. Both compounds crystallize as centrosymmetric dimers in which weak CH/π intra- and interdimer interactions are responsible for arrangement in crystal structure.     

Discovery of Novel Tricyclic 5H-Pyridazino[4,5-b]indoles as Potent Antitumor Agents: Design,Synthesis and Biological Evaluation

A novel series of 5H-pyridazino[4,5-b]indoles(L-01-L-32) was synthesized and characterized by means of ¹H NMR, MS and elemental analysis. The cytotoxicity of the target compounds against Bel-7402 and HT-1080 cell lines were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assay. Most of them exhibited moderate to excellent cytotoxicity, and six compounds(L-04, L-06, L-18, L-20, L-21 and L-23) possessed dramatically increased cytotoxicity superior to Gefitinib. Of these initial hits, compound L-21 displayed remarkable cytotoxicity against the tested cell lines with half maximal inhibitory concentration(IC₅₀) values of 4.6 and 2.1 μmol/L, respectively, which was 13.9- to 25.6-fold more potent than positive control.     

Preparation and root growth-inhibitory activity of N-substituted 2-(2-chloroacetamido)-3-(furan-2-yl)propanamides

A series of N-substituted 2-(2-chloroacetamido)-3-(furan-2-yl)propanamides (16--18) was prepared through the reaction of chloroacetyl chloride with N-substituted 2-amino-3-(furan-2-yl)propanamides (15), which were obtained via condensation of 2-(tert-butoxycarbonylamido)-3-(furan-2-yl)propanoic acid (Boc-furylalanine) (8) with amines (9, 11, 13), followed by hydrolysis of the resultant N-substituted Boc-furylalanine acid amides (10, 12, 14) in the presence of HCl/dioxane. The biological activity of the prepared 16, 17 and 18 as root growth inhibitors was examined by germination assay using rape seed. At the concentration of 5.0 x10 (-5) M, the most active compound, 2-(2-chloroacetamido)-N-(2,6-diethylphenyl)-3-(furan-2-yl)propanamide (16 n), showed potent root growth-inhibitory activity of 76% towards rape seedlings.